CN104306854A - Medicine for treating autism and preparation method thereof - Google Patents
Medicine for treating autism and preparation method thereof Download PDFInfo
- Publication number
- CN104306854A CN104306854A CN201410622090.8A CN201410622090A CN104306854A CN 104306854 A CN104306854 A CN 104306854A CN 201410622090 A CN201410622090 A CN 201410622090A CN 104306854 A CN104306854 A CN 104306854A
- Authority
- CN
- China
- Prior art keywords
- parts
- fructus
- medicine
- pure water
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 42
- 206010003805 Autism Diseases 0.000 title claims abstract description 17
- 208000020706 Autistic disease Diseases 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title abstract description 5
- 229940079593 drug Drugs 0.000 title description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229930006000 Sucrose Natural products 0.000 claims abstract description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims description 20
- 241000628997 Flos Species 0.000 claims description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 6
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 6
- 210000000582 semen Anatomy 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 244000001632 Acorus gramineus Species 0.000 abstract 1
- 235000013073 Acorus gramineus Nutrition 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 240000005250 Chrysanthemum indicum Species 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 241000237502 Ostreidae Species 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 240000007651 Rubus glaucus Species 0.000 abstract 1
- 235000011034 Rubus glaucus Nutrition 0.000 abstract 1
- 235000009122 Rubus idaeus Nutrition 0.000 abstract 1
- 235000008326 Trichosanthes anguina Nutrition 0.000 abstract 1
- 244000078912 Trichosanthes cucumerina Species 0.000 abstract 1
- 240000000038 Ziziphus mauritiana Species 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 235000020636 oyster Nutrition 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 230000006399 behavior Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000008451 emotion Effects 0.000 description 3
- 230000008449 language Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 238000012549 training Methods 0.000 description 3
- 208000036626 Mental retardation Diseases 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 238000005485 electric heating Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000002893 slag Substances 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 206010054196 Affect lability Diseases 0.000 description 1
- 206010001488 Aggression Diseases 0.000 description 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 229940121891 Dopamine receptor antagonist Drugs 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- 206010021567 Impulsive behaviour Diseases 0.000 description 1
- DUGOZIWVEXMGBE-UHFFFAOYSA-N Methylphenidate Chemical compound C=1C=CC=CC=1C(C(=O)OC)C1CCCCN1 DUGOZIWVEXMGBE-UHFFFAOYSA-N 0.000 description 1
- 208000012202 Pervasive developmental disease Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 206010043118 Tardive Dyskinesia Diseases 0.000 description 1
- 230000016571 aggressive behavior Effects 0.000 description 1
- 208000012761 aggressive behavior Diseases 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 230000000561 anti-psychotic effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 208000029560 autism spectrum disease Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003210 dopamine receptor blocking agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 229960001344 methylphenidate Drugs 0.000 description 1
- 238000001671 psychotherapy Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/13—Preparation or pretreatment of starting material involving cleaning, e.g. washing or peeling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for treating autism and a preparation method of the medicine, and belongs to the technical field of traditional Chinese medicines. The medicine is prepared from the following raw materials: 30 parts of white peony roots, 20 parts of Chinese yam, 20 parts of Chinese dates, 20 parts of coix seeds, 20 parts of haws, 20 parts of Chinese wolfberry, 30 parts of grassleaf sweetflag rhizomes, 10 parts of radix puerariae, 20 parts of chrysanthemums and 1000 parts of pure water. In addition, 200 parts of fructus alpiniae oxyphyllae, 200 parts of snakegourd fruits, 200 parts of oysters, 200 parts of Indian bread with hostwood, 150 parts of raspberry, 100 parts of white sugar and 1000 parts of pure water are added. The medicine is carefully processed by using natural Chinese herbal medicines as the raw materials, and is used for the treatment and the rehabilitation of autism children. The medicine disclosed by the invention is safe and has no side effects.
Description
?
Technical field
The invention discloses a kind of medicine for the treatment of infantile autism and preparation method thereof, belong to technical field of Chinese medicines.
Background technology
Infantile autism, is also childhood autism, is a kind of hypotype of pervasive developmental disorders, common with male, and onset is in infantile period, and main manifestations is speech dysplasia, Social disorder in various degree, interest is narrow and way of act is mechanical.About have the patient of 3/4 with obvious mental retardation, part infant has good ability in certain under the background of general mental retardation.
This disease prevalence 3 ~ 4/0,000.But report has the trend increased in recent years, and according to the data of NIH's Mental Health institute (NIMH), U.S.'s autism prevalence is 1 ‰ ~ 2 ‰.Domestic have no autistic the whole nation stream adjusting data, only relevant report has been made in some areas, as 2010 report, Guangdong autism prevalence is 0.67%, and Shenzhen area is up to 1.32%.
Therapeutic Method main at present comprises training interference method and Drug therapy.
Although current autistic interference method is a lot, mostly lack the evidence of evidence-based medicine EBM.There is no optimum treatment scheme, best Therapeutic Method should be the treatment of individuation.Wherein, business initiatives, education and training is the most effective, topmost Therapeutic Method.Target promotes patient's development of speech, improves social contact ability, grasps basic living technical ability and learning skill.
Current Drug therapy there is no method and changes the autistic course of disease, also the specific drug for the treatment of core symptom is lacked, but medicine can improve some emotions and the behavior symptom of patient, as emotional lability, attention deficit and many dynamic, impulsive behavior, aggressive behavior, self inflicted injury and suicide, twitch and obsessive symptoms and psychotic symptoms etc., be conducive to safeguarding patient self or other people safety, implementing education and training and psychotherapy smoothly.Common drug is as follows: central stimulant, is applicable to merge attention deficit and hyperkinetic syndrome shape person.Common drug is methylphenidate.Antipsychotic drug, answers low dose of, short-period used, in use will note drug side effect, particularly EPS.Antidepressant drug, can alleviate repetition stereotyped behavior, obsessive symptoms, improve emotional problem, improves social and communication skill, and for using the dyskinesia that occurs after dopamine receptor antagonist as shunk back, tardive dyskinesia, twitch etc. also have certain effect.
The medicament categories being used for the treatment of now infantile autism is various, has Western medicine, Chinese medicine, biological medicament etc., but curative effect is all not good.A kind of ideal is not also had to be used for the treatment of the medicine of infantile autism at present.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of medicine for the treatment of infantile autism, and this medicine is the pharmaceutical composition that raw material is prepared from by pure natural plant, the present invention also discloses the preparation method of this pharmaceutical composition.
Medicine of the present invention is prepared as follows:
1) combination A is prepared by following weight portion:
Radix Paeoniae Alba 30-35 part, Rhizoma Dioscoreae 20-30 part, Fructus Jujubae 20-25 part, Semen Coicis 20-25 part, Fructus Crataegi 20-25 part, Fructus Lycii 20-25 part, Rhizoma Acori Graminei 30-35 part, Radix Puerariae 10-15 part, Flos Chrysanthemi 20-25 part, pure water 1000 ~ 2000 parts;
2) combination B is prepared by following weight portion:
Fructus Alpiniae Oxyphyllae 200-250 part, Fructus Trichosanthis 200-250 part, Concha Ostreae 200-250 part, Poria cum Radix Pini 200-250 part, Fructus Rubi 150-200 part, white sugar 100-120 part, pure water 1000 ~ 2000 parts;
3), after combination A and combination B being boiled 1 ~ 2 hour, leach medicinal liquid A and medical liquid B respectively, be chilled to room temperature, remove medicinal residues, and medicinal liquid A and medical liquid B are regulated pH to 8 respectively;
4) isopyknic medicinal liquid A and medical liquid B mixing is got, for subsequent use.
Preferred as one, combination A is by following weight: the Radix Paeoniae Alba 30 parts, Rhizoma Dioscoreae 20 parts, 20 parts, Fructus Jujubae, Semen Coicis 20 parts, Fructus Crataegi 20 parts, Fructus Lycii 20 parts, Rhizoma Acori Graminei 30 parts, Radix Puerariae 10 parts, Flos Chrysanthemi 20 parts, pure water 1000 parts.
Preferred as one, combination B is by following weight: Fructus Alpiniae Oxyphyllae 200 parts, Fructus Trichosanthis 200 parts, Concha Ostreae 200 parts, Poria cum Radix Pini 200 parts, Fructus Rubi 150 parts, white sugar 100 parts, pure water 1000 parts.
The present invention proves through a large amount of clinical practice, for treating the evident in efficacy of infantile autism, and has no side effect, and is the ideal medicament for the treatment of infantile autism.
The remarkable advantage of medicine of the present invention is pure natural plant Chinese herbal medicine, has no side effect, no dependence, good effect.
Detailed description of the invention
Embodiment 1
(1) Radix Paeoniae Alba 30 parts is got, Rhizoma Dioscoreae 20 parts, 20 parts, Fructus Jujubae, Semen Coicis 20 parts, Fructus Crataegi 20 parts, Fructus Lycii 20 parts, Rhizoma Acori Graminei 30 parts, Radix Puerariae 10 parts, Flos Chrysanthemi 20 parts, pure water 1000 parts.
(2) Fructus Alpiniae Oxyphyllae 200 parts is separately added, Fructus Trichosanthis 200 parts, Concha Ostreae 200 parts, Poria cum Radix Pini 200 parts, Fructus Rubi 150 parts, white sugar 100 parts, pure water 1000 parts.
Selected, cleaning, places the above-mentioned Chinese medicine processed respectively in electric heating type shedder, boils respectively, filtering medicinal liquid after 2 hours, removes respectively and abandons the Chinese medicine slag boiled.
(3), after medicinal liquid prepared by the Chinese medicine composition of step (1) and (2) being placed cooling, test its acid-base value with accurate pH test paper respectively, with acetic acid or sodium bicarbonate solution, it is modulated to 8.
(4) by each 500ml of medicinal liquid equivalent for preparing of the Chinese medicine composition of the step (1) of becoming reconciled and (2) import 1000ml simultaneously glass container in stir evenly, for subsequent use.
(5) with the medicinal liquid prepared by glass vial splendid attire step (4), every bottle of 500ml, labeling is for subsequent use.
Embodiment 2
(1) Radix Paeoniae Alba 35 parts is got, Rhizoma Dioscoreae 30 parts, 25 parts, Fructus Jujubae, Semen Coicis 25 parts, Fructus Crataegi 25 parts, Fructus Lycii 25 parts, Rhizoma Acori Graminei 35 parts, Radix Puerariae 15 parts, Flos Chrysanthemi 25 parts, pure water 2000 parts.
(2) Fructus Alpiniae Oxyphyllae 250 parts is separately added, Fructus Trichosanthis 250 parts, Concha Ostreae 250 parts, Poria cum Radix Pini 250 parts, Fructus Rubi 200 parts, white sugar 120 parts, pure water 2000 parts.
Selected, cleaning, the above-mentioned Chinese medicine processed is placed in electric heating type shedder respectively, and the 1000ml that adds water respectively boils, filtering medicinal liquid after 2 hours, removes respectively and abandons the Chinese medicine slag boiled.
(3), after medicinal liquid prepared by the Chinese medicine composition of step (1) and (2) being placed cooling, test its acid-base value with accurate pH test paper respectively, with acetic acid or sodium bicarbonate solution, it is modulated to 8.
(4) by each 500ml of medicinal liquid equivalent for preparing of the Chinese medicine composition of the step (1) of becoming reconciled and (2) import 1000ml simultaneously glass container in stir evenly, for subsequent use.
(5) with the medicinal liquid prepared by glass vial splendid attire step (4), every bottle of 500ml, labeling is for subsequent use.
The using method of the Chinese medicine for the treatment of infantile autism provided by the present invention is as follows: in 6 years old, one day morning and evening of child before the meal respectively once, the course for the treatment of in March one.More than 6 years old morning, noon and afternoon before the meal each once, the course for the treatment of in March one.
Adopt medicine provided by the present invention, applicant place rehabilitation center has seen and treated patients about 500 children.From clinical efficacy, through the treatment of a course for the treatment of, total effective 300 people, effective 182 people, invalid 18 people.Obvious effective rate is 60%, and effective percentage is 36.4%, obtains good clinical effectiveness.(note: invalid finger is taken medicine after a course for the treatment of without any change; Effective finger to be taken medicine after a course for the treatment of in emotion, and behavior and language change; Effective finger in emotion, behavior and language acknowledging has made marked progress after a course for the treatment of of taking medicine, and emotion-directed behavior problem reduces, and language increases, and can set up basic daily communication with father and mother.）
Below the representative instance taking product of the present invention:
Case one, Lee, four years old, people from Qichun, Hubei, from 2 years old, show solitarily unsocial, do not understand instruction, a word was not said, absent minded, does not see people.In April, 2012, when checking treatment at center, center determined to carry out Chinese medicine conditioning to it.Result is that conditioning has just had normal speech in 32 days afterwards, in May 6 center in 2012, and infant embraces suddenly the face parent of mother flatly, really earnestly be a sound mother, the mother of infant said in tears at that time: " I hears that son is my mother finally." at that time the grandparents of child also flowed down exciting tear at the scene.
Case two, Chen, female, 7 years old, people from Shiyan, Hubei.Found that it was hypologia from about 3 years old, murmur to oneself, solitarily peel off, not too listen instruction, mechanical repetition, IQ is on the low side.Autism of children is diagnosed as in healthcare hospital for women & children of Hubei Province.On June 10th, 2011 starts in center rehabilitation medication, and in JIUYUE, 2012 returns to one's perfect health and normally goes to school.Because IQ is on the low side, just upper class hour low academic, child does not usually remember the knowledge of study, and its female requirement continues to take, and IQ raising in 2013, school grade reaches medium level.
Claims (3)
1. treat a medicine for infantile autism, it is characterized in that preparing as follows:
1) combination A is prepared by following weight portion:
Radix Paeoniae Alba 30-35 part, Rhizoma Dioscoreae 20-30 part, Fructus Jujubae 20-25 part, Semen Coicis 20-25 part, Fructus Crataegi 20-25 part, Fructus Lycii 20-25 part, Rhizoma Acori Graminei 30-35 part, Radix Puerariae 10-15 part, Flos Chrysanthemi 20-25 part, pure water 1000 ~ 2000 parts;
2) combination B is prepared by following weight portion:
Fructus Alpiniae Oxyphyllae 200-250 part, Fructus Trichosanthis 200-250 part, Concha Ostreae 200-250 part, Poria cum Radix Pini 200-250 part, Fructus Rubi 150-200 part, white sugar 100-120 part, pure water 1000 ~ 2000 parts;
3), after combination A and combination B being boiled 1 ~ 2 hour, leach medicinal liquid A and medical liquid B respectively, be chilled to room temperature, remove medicinal residues, and medicinal liquid A and medical liquid B are regulated pH to 8 respectively;
4) isopyknic medicinal liquid A and medical liquid B mixing is got, for subsequent use.
2. medicine according to claim 1, is characterized in that, described combination A is by following weight: the Radix Paeoniae Alba 30 parts, Rhizoma Dioscoreae 20 parts, 20 parts, Fructus Jujubae, Semen Coicis 20 parts, Fructus Crataegi 20 parts, Fructus Lycii 20 parts, Rhizoma Acori Graminei 30 parts, Radix Puerariae 10 parts, Flos Chrysanthemi 20 parts, pure water 1000 parts.
3. medicine according to claim 1, is characterized in that, described combination B is by following weight: Fructus Alpiniae Oxyphyllae 200 parts, Fructus Trichosanthis 200 parts, Concha Ostreae 200 parts, Poria cum Radix Pini 200 parts, Fructus Rubi 150 parts, white sugar 100 parts, pure water 1000 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410622090.8A CN104306854A (en) | 2014-11-07 | 2014-11-07 | Medicine for treating autism and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410622090.8A CN104306854A (en) | 2014-11-07 | 2014-11-07 | Medicine for treating autism and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104306854A true CN104306854A (en) | 2015-01-28 |
Family
ID=52362263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410622090.8A Pending CN104306854A (en) | 2014-11-07 | 2014-11-07 | Medicine for treating autism and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104306854A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105148041A (en) * | 2015-09-10 | 2015-12-16 | 林国良 | Rehabilitation-assisted traditional Chinese medicine for pediatric infantile autism |
| CN105833003A (en) * | 2016-05-18 | 2016-08-10 | 孙新永 | Traditional Chinese medicine composition for treating autism |
| CN110916192A (en) * | 2019-11-25 | 2020-03-27 | 垒途智能教科技术研究院江苏有限公司 | Probiotic mineral powder capable of preventing and treating autism of children and teenagers and application thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102671053A (en) * | 2012-06-11 | 2012-09-19 | 原志成 | Medicament for treating autism and preparation method thereof |
| CN103055231A (en) * | 2013-01-22 | 2013-04-24 | 南宁市神明药物研究所有限责任公司 | Method for preparing traditional Chinese medicine preparation |
-
2014
- 2014-11-07 CN CN201410622090.8A patent/CN104306854A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102671053A (en) * | 2012-06-11 | 2012-09-19 | 原志成 | Medicament for treating autism and preparation method thereof |
| CN103055231A (en) * | 2013-01-22 | 2013-04-24 | 南宁市神明药物研究所有限责任公司 | Method for preparing traditional Chinese medicine preparation |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105148041A (en) * | 2015-09-10 | 2015-12-16 | 林国良 | Rehabilitation-assisted traditional Chinese medicine for pediatric infantile autism |
| CN105833003A (en) * | 2016-05-18 | 2016-08-10 | 孙新永 | Traditional Chinese medicine composition for treating autism |
| CN110916192A (en) * | 2019-11-25 | 2020-03-27 | 垒途智能教科技术研究院江苏有限公司 | Probiotic mineral powder capable of preventing and treating autism of children and teenagers and application thereof |
| CN110916192B (en) * | 2019-11-25 | 2021-04-13 | 垒途智能教科技术研究院江苏有限公司 | Probiotic mineral powder capable of preventing and treating autism of children and teenagers and application thereof |
| WO2021102910A1 (en) * | 2019-11-25 | 2021-06-03 | 垒途智能教科技术研究院江苏有限公司 | Probiotic mineral powder capable of preventing and treating infantile autism of children and adolescents, and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102293301A (en) | Health care tea with hypnosis effect and preparation method | |
| CN104306854A (en) | Medicine for treating autism and preparation method thereof | |
| CN103989935B (en) | A kind of tranquilizing by nourishing the heart medicated wine and preparation method thereof | |
| CN107296863A (en) | A kind of medicine for treating senile dementia | |
| CN102716307B (en) | Prepared common monkshood daughter root Chinese medicinal preparation for treating hypersomnia and preparation method thereof | |
| CN104223073B (en) | A kind of food, health products or pharmaceutical composition of sleeping | |
| CN104719538B (en) | A kind of preparation method of bamboo salt tea | |
| CN110367531A (en) | A kind of rose medicine mulberry cream and preparation method thereof | |
| CN102908396B (en) | Chinese medicinal composition for promoting sleeping and preparation method thereof | |
| CN105535777A (en) | Composition for weight reduction and lipid decreasing | |
| CN104258023B (en) | Traditional Chinese medicine composition for treating depressive disorder | |
| CN104274643B (en) | A kind of Chinese medicine for treating infantile pneumonia | |
| CN102793870A (en) | Chinese herbal medicine for treating renal calculi | |
| CN102698004B (en) | Grassleaf sweelflag rhizome Chinese herbal preparation for relieving depressive disorders and preparation method of same | |
| CN100998744A (en) | Chinese patent drug for treating infantile hyperkinetic syndrome | |
| CN1686514A (en) | Chinese medicinal preparation for treating anxietas, depression and its production method | |
| CN101612361A (en) | A kind of medicine for the treatment of Menieres disease and preparation method thereof | |
| CN102526570A (en) | Foot bath Chinese medicinal composition for treating cough | |
| CN108785452A (en) | A kind of preparation method for treating halitosis disease Chinese medicine composition | |
| CN107375693A (en) | A kind of traditional Chinese medicine health care product for strengthening immunity of organisms and preparation method thereof | |
| CN103495044B (en) | Pure traditional Chinese medicine preparation for treating neurosis | |
| Suchday et al. | Ayurveda: an alternative in the United States | |
| Chunwu | Origin and prevention of a new type of pneumonia coronavirus | |
| CN104524245A (en) | Traditional Chinese medicine composition for treating attention deficit hyperactivity disorder and preparation thereof | |
| CN104398882A (en) | Traditional Chinese medicine composition for treating insomnia caused by internally attacking phlegm-heat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150128 |
|
| WD01 | Invention patent application deemed withdrawn after publication |